Fujifilm Diosynth celebrates expansion in Denmark

By The Science Advisory Board staff writers

March 4, 2021 -- Contract development and manufacturing organization (CDMO) Fujifilm Diosynth Biotechnologies held a ceremony on March 3 to celebrate the large-scale expansion of cell culture capacity at its production facility in Hillerød, Denmark.

The expansion project includes the addition of six 20,000-L bioreactors, which represents a doubling of the facility's bulk drug substance production capacity and the installation of fill/finish capability to support production of approximately 35 million units per year, Fujifilm Diosynth said in a statement.

Turning of the soil at Fujifilm Diosynth Biotechnologies in Denmark signals the start of expansion project. Image courtesy of Fujiflim Diosynth.

The revamp was made possible by a capital investment of 100 billion yen ($928 million U.S.) from parent company Fujifilm. Fujifilm Diosynth said that it is adding 300 staff in Denmark by the end of 2023 to support new activities.


Copyright © 2021 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?